John BannisterGlobal Health Regional Sales Directorjbannister@omegadiagnostics.co.uk

TITLE

VISITECT® CD4 PoC Smartphone App

mHealth Solutions

Founded in 2004, Omega Diagnostics Group PLC is focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease.

To improve human health and well-being through innovative diagnostic tests and global partnerships

Our Mission

100+ Countries

• Over 25 years experience of manufacturing and exporting IVD diagnostics products to over 100 countries including many with resource limited facilities.

• VISITECT® CD4 developed in partnership with the Burnet Institute (Melbourne, Aus) with funding provided by the Bill & Melinda Gates Foundation

• Android Smartphone App developed on Samsung platform for reading, interpretation and reporting VISITECT® CD4 POC

• RDT pipeline is mHealth orientated

Partnerships